Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Manal Ghazzawi"'
Autor:
Onome T. Abiri, Abdulai J. Bah, Michael Lahai, Durodami R. Lisk, James P. Komeh, Joy Johnson, Wiltshire C. N. Johnson, Sheku S. Mansaray, Joseph Sam Kanu, James B. W. Russell, Fawzi Thomas, Murtada M. Sesay, Thomas A. Conteh, Alphan Tejan-Kella, Mohamed Sesay, Manal Ghazzawi, Brian Thompson, Sorie Conteh, Gibrilla Fadlu Deen
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-8 (2022)
Abstract Clinical trials during public health emergencies of novel medical products such as therapeutics and vaccines in resource-limited settings are daunting due to the limited capacity for regulatory assessment. Regulating clinical trials during t
Externí odkaz:
https://doaj.org/article/ee5d2605c278459a9594dbd0606eddd6
Autor:
Manal Ghazzawi, Sahr A. Yendewa, Peter B. James, Samuel P. Massaquoi, Lawrence S. Babawo, Foday Sahr, Gibrilla F. Deen, Mustapha Kabba, Ponsiano Ocama, Sulaiman Lakoh, Robert A. Salata, George A. Yendewa
Publikováno v:
Healthcare, Vol 11, Iss 2, p 177 (2023)
Hepatitis B virus (HBV) is a major global health challenge. Emerging evidence suggests that poor knowledge and stigma are impacting HBV control efforts in sub-Saharan Africa (SSA), but their role is not well understood. We conducted a cross-sectional
Externí odkaz:
https://doaj.org/article/816788608ee144ee816dbfc3dd9098e7
Autor:
Sahr A. Yendewa, Manal Ghazzawi, Peter B. James, Mohamed Smith, Samuel P. Massaquoi, Lawrence S. Babawo, Gibrilla F. Deen, James B. W. Russell, Mohamed Samai, Foday Sahr, Sulaiman Lakoh, Robert A. Salata, George A. Yendewa
Publikováno v:
Vaccines, Vol 10, Iss 5, p 757 (2022)
Despite having safe and efficacious vaccines against COVID-19, vaccine hesitancy is widespread. Although a trusted source of information, vaccine hesitancy has been reported among healthcare professionals, yet few studies have explored this phenomeno
Externí odkaz:
https://doaj.org/article/4516eb3892394ec5a5d7ee49d948418c
Autor:
Manal Ghazzawi, Peter B. James, Samuel P. Massaquoi, Sahr A. Yendewa, Robert A. Salata, George A. Yendewa
Publikováno v:
Pathogens, Vol 11, Iss 2, p 243 (2022)
Hepatitis B (HBV) is a major public health threat in Sierra Leone. Pregnant women are disproportionately impacted, yet little is known about the epidemiology of HBV in this group. We conducted a cross-sectional study of pregnant women aged ≥16 year
Externí odkaz:
https://doaj.org/article/0a822e1ce49f41cbbebfa06984b18485
Autor:
Manal Ghazzawi, Lawrence S. Babawo, Amir M. Mohareb, Peter B. James, Sahr A. Yendewa, Samuel P.E. Massaquoi, Peterlyn E. Cummings, Sulaiman Lakoh, Robert A. Salata, George A. Yendewa
BackgroundThere are limited studies evaluating the impact of COVID-19-related interruptions on hepatitis B virus (HBV) screening in endemic countries in Sub-Saharan Africa.MethodsWe conducted a retrospective study of HBV testing in a community pharma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d99b3f9b3bd5cec4d6f4bb2b64d1ef90
https://doi.org/10.1101/2023.05.24.23290418
https://doi.org/10.1101/2023.05.24.23290418
Autor:
George A. Yendewa, Peter B. James, Amir M. Mohareb, Umaru Barrie, Samuel P.E. Massaquoi, Sahr A. Yendewa, Manal Ghazzawi, Tahir Bockarie, Peterlyn E. Cumming, Ibrahima S. Diallo, Ambulai Johnson, Benjamin Vohnm, Lawrence S. Babawo, Gibrilla F. Deen, Mustapha Kabba, Foday Sahr, Sulaiman Lakoh, Robert A. Salata
Vaccination against hepatitis B virus (HBV) is effective at preventing mother-to-child transmission. Sierra Leone, Liberia and Guinea are hyperendemic West African countries; yet childhood immunization coverage is suboptimal and barriers to immunizat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::389fe394369e9292f4e958bd90035fac
https://doi.org/10.1101/2023.03.16.23287374
https://doi.org/10.1101/2023.03.16.23287374
Autor:
Manal Ghazzawi, Sahr Yendewa, Peter B. James, Samuel P. Massaquoi, Lawrence S. Babawo, Foday Sahr, Gibrilla F. Deen, Mustapha Kabba, Ponsiano Ocama, Sulaiman Lakoh, Robert A. Salata, George A. Yendewa
Hepatitis B virus (HBV) is a major global health challenge. Emerging evidence suggests that poor knowledge and stigma are impacting HBV control efforts in sub-Saharan Africa (SSA), however their role is not well understood. We conducted a cross-secti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::012232bc9675a0d4a68721f8eef7a5af
Autor:
Onome T. Abiri, Abdulai J. Bah, Michael Lahai, Durodami R. Lisk, James P. Komeh, Joy Johnson, Wiltshire C. N. Johnson, Sheku S. Mansaray, Joseph Sam Kanu, James B. W. Russell, Fawzi Thomas, Murtada M. Sesay, Thomas A. Conteh, Alphan Tejan-Kella, Mohamed Sesay, Manal Ghazzawi, Brian Thompson, Sorie Conteh, Gibrilla Fadlu Deen
Publikováno v:
Trials. 23(1)
Clinical trials during public health emergencies of novel medical products such as therapeutics and vaccines in resource-limited settings are daunting due to the limited capacity for regulatory assessment. Regulating clinical trials during the Ebola
Publikováno v:
TMR Integrative Medicine. 5:e21034
Autor:
Wenbo Xu, Jingxin Li, Zhe Zhang, Wen-Jiao Yin, Guo Qiang, Li-Hua Hou, Fengcai Zhu, Xu Zhang, Wen-Juan Wang, Wei Chen, Yuemei Hu, Manal Ghazzawi, Shipo Wu, Abdul R Wurie, Qi Liang, Yu-Hua Li, Alie H Wurie, Junzhi Wang, James B W Russell, Lei Duan
Publikováno v:
Lancet (London, England). 389(10069)
Summary Background A recombinant adenovirus type-5 vector-based vaccine expressing the glycoprotein of Ebola Zaire Makona variant showed good safety and immunogenicity in a phase 1 trial of healthy Chinese adults. We aimed to assess the safety and im